PDS Biotechnology Corp Shareholders' Equity
PDS Biotechnology Corp (PDSB) had Shareholders' Equity of -$3.58 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$3.58M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.89M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.25M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.45M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$3.58M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.89M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $9.25M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $9.45M 10-K · filed 2026-03-30 | |
| 2025-06-30 | $15.96M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $22.36M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $19.00M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $22.00M 10-K · filed 2026-03-30 | |
| 2024-06-30 | $30.92M 10-K · filed 2026-03-30 | |
| 2024-03-31 | $37.18M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $26.13M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $24.48M 10-K · filed 2025-03-27 | |
| 2023-06-30 | $32.44M 10-K · filed 2025-03-27 | $32.44M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $41.01M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $44.00M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $47.06M 10-K · filed 2024-03-28 | |
| 2022-06-30 | $51.43M 10-K · filed 2024-03-28 | |
| 2022-03-31 | $55.87M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $63.21M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $67.86M 10-K · filed 2023-03-28 | |
| 2021-06-30 | $72.99M 10-K · filed 2023-03-28 | |
| 2021-03-31 | $24.37M 10-K · filed 2023-03-28 | |
| 2020-12-31 | $27.13M 10-K · filed 2023-03-28 | |
| 2020-09-30 | $31.02M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $17.01M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $19.89M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $11.70M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $15.58M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $20.61M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $24.45M 10-Q · filed 2020-08-13 | $24.45M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$2.07M 10-K · filed 2021-03-18 | $29.84M 10-K · filed 2019-02-21 |
| 2018-09-30 | -$1.08M 10-Q · filed 2019-11-07 | $30.98M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$807.61K 10-Q · filed 2019-11-07 | $33.34M 10-Q · filed 2018-08-01 |
| 2018-03-31 | -$284.41K 10-Q · filed 2019-08-01 | $44.28M 10-Q · filed 2018-05-01 |
| 2017-12-31 | -$609.53K 10-K · filed 2020-03-27 | $62.37M 10-K · filed 2018-03-01 |
| 2017-09-30 | $74.65M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $84.27M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $78.65M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $89.28M 10-K · filed 2019-02-21 | |
| 2016-09-30 | $97.51M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $106.76M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $114.72M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $122.48M 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$50.64M 10-Q · filed 2015-11-06 | |
| 2014-12-31 | -$27.83M 10-K · filed 2018-03-01 | -$27.83M 10-Q · filed 2015-11-06 |
| 2013-12-31 | -$15.35M 10-K · filed 2017-03-02 | |
| 2012-12-31 | -$7.65M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |